Table 4.
Characteristics of the Saudi Biobank population taking antihypertensive medications with BP above treatment goals according to 2017 ACC/AHA guideline and JNC-7 guideline, 2017–2020
| BP above goal according to | |||
| ACC (n=287) | JNC-7 (n=161) | ACC but not JNC-7 (n=126) | |
| Age Mean (SD) |
37.26 (9.94) | 39.71 (9.72) | 34.13 (9.35) |
| Male gender, % | 40.07 | 45.34 | 33.33 |
| Tobacco use, % | 7.80 | 6.96 | 8.87 |
| Diabetes, % | 35.89 | 46.58 | 22.22 |
| CVD, % | 25.09 | 24.84 | 25.40 |
| BMI, kg/m2 | |||
| Underweight | 4.18 | 2.48 | 6.35 |
| Normal weight | 28.92 | 26.71 | 31.75 |
| Overweight | 32.06 | 29.19 | 35.71 |
| Obese | 30.66 | 34.78 | 25.40 |
| Extremely obese | 4.18 | 6.83 | 0.79 |
| Waist circum., cm | |||
| Not normal, % | 56.45 | 63.98 | 46.83 |
| Waist–hip ratio | |||
| Not normal, % | 42.16 | 44.72 | 38.89 |
| Systolic blood pressure Mean (SD) |
135.11 (17.21) | 144.07 (15.99) | 123.65 (10.71) |
| Diastolic blood pressure Mean (SD) |
88.65 (15.91) | 93.42 (19.45) | 82.56 (5.34) |
| Number of antihypertensive medications | |||
| 1 | 45.51 | 41.59 | 52.31 |
| 2 | 29.78 | 31.86 | 26.15 |
| 3 | 7.87 | 7.96 | 7.69 |
| 4 | 8.99 | 8.85 | 9.23 |
| ≥5 | 7.87 | 9.73 | 4.62 |
ACC/AHA, American College of Cardiology and the American Heart Association; BMI, body mass index; BP, blood pressure; CVD, cardiovascular disease; JNC-7, Joint National Committee 7 Blood Pressure Guideline.